Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Gyrablock 400 mg, film-coated tablets.
| Pharmaceutical Form |
|---|
|
Film-coated tablet. Yellow, capsule shaped, convex, scored on one side, film-coated tablet. |
Each tablet contains 400 mg of norfloxacin.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Norfloxacin |
Norfloxacin has a rapid bactericidal action and inhibits synthesis of bacterial deoxyribonucleic acid (DNA). Norfloxacin has a broad spectrum of antibacterial activity against gram-positive and gram-negative aerobic bacteria. |
| List of Excipients |
|---|
|
Tablets also contain croscarmellose sodium, povidone, microcrystalline cellulose, magnesium stearate, Opadry Yellow 02B220005 and polyethylene glycol 6000. |
Polypropelene securitainer packs, with a leaflet, in a carton. Securitainers of 14, 500 and 1000 tablets, blisters of 14, 20, 30, 50, 100 are available.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
11772
30/6/1988
| Drug | Countries | |
|---|---|---|
| GYRABLOCK | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
